Expert Rev Cardiovasc Ther. 2008;6(2):261-274. © 2008 Expert Reviews Ltd. Cite this: Coronary Artery Bifurcation Lesion Classifications, Interventional Techniques ...
Please provide your email address to receive an email when new articles are posted on . A novel stent for treating long coronary lesions met its primary performance goal at 1 year. The 48-mm stent was ...
The study highlights the importance of proper lesion preparation in the DCB-only strategy for de novo left main coronary artery disease. It also emphasizes the potential benefits of this approach, ...
PHOENIX -- The novel, next-generation Xience drug-eluting stent (DES) with a 48-mm length met the performance bar with a particularly low restenosis rate, the SPIRIT 48 trial showed. The Xience ...
Patients with CKD had twice the risk of target vessel failure after PCI compared with patients without CKD. The benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) extend ...
The C-reactive protein to albumin ratio is a novel inflammation marker that may be a valuable predictor of coronary artery lesion formation in Kawasaki disease. C-reactive protein to albumin ratio ...
A unique metallic DES that “uncages” the artery and allows for positive adaptive remodeling has shown solid findings through 1 year in a small study of patients with single de novo coronary lesions, ...
Coronary artery lesions in patients with SARS-CoV-2 infection more likely to become high-risk plaques. (HealthDay News) — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is ...
Please provide your email address to receive an email when new articles are posted on . Results from the INFINITY-SWEDEHEART trial showed that Elixir Medical’s drug-eluting coronary implant was ...
The disparate cutoffs may help determine whether a patient should go to the cath lab. Prospective validation comes next.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback